This site uses cookies to store information on your computer. I'm fine with this Cookie information
Follow is on Twitter Like us on Facebook Follow us on Instagram

We have started moving content to our new website at: www.nhsggc.scot

COVID-19 (Coronavirus info)

Information and guidance for public, NHSGGC staff, and community-based services.  Hospital visiting restrictions now in place.

Anti - Mullerian Hormone (AMH)

Anti-Mullerian hormone (AMH) is a protein produced by granulosa cells of the ovaries in females and by Sertoli cells of the testes in males.

In women serum AMH concentration increases with age up until the mid-twenties, after which it begins to decline. AMH correlates well with the number of follicles in the ovary (as measured by ultrasound) in women over the age of 25 and its measurement is used to individualise fertility treatment.

In men serum AMH concentration tends to be high in childhood, then declines through puberty to low levels in adulthood. It is used in the investigation of cryptorchidism and anorchidism.

AMH is elevated in the majority of patients with granulosa cell tumours and may be used to monitor disease progression or recurrence. AMH is also useful in the investigation of disorders of sex development as a marker of testicular activity.

Sample Requirements and Reference Ranges

Sample type  Serum
Container  SST
Precautions  Separate serum and send via first class post. If there will be >48 h before sending store the specimen at -20°C. Sample can be sent at  ambient temperature.
Minimum volume  2 mL
Reference range

 Females           <50 pmol/L in young adults (falls steadily towards menopause where it becomes undetectable)

 Males (Levels fall at puberty. These ranges were derived from a study where stage of puberty was not determined)

 0-1yr                390-1300 pmol/L

 1-4yr                300-1700 pmol/L

 5-8yr                260-1200 pmol/L

 9-12yr              100-1000 pmol/L

 13-16yr            40-560 pmol/L

 Adults             <100 pmol/L (literature value)

Turnaround time  14 days
Method  Beckman Access
 
Quality Assurance
UK NEQAS
Last Updated: 20 September 2019